Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Congresses

EASD

2025/09/15-2025/09/19

Vienna

61st edition of the Annual Meeting of the European Association for the Study of Diabetes (EASD)

The EASD Annual Meeting is one of the largest diabetes-related conferences in the world with almost 13,000 participants from around the world. Each year, the scientific programme of the conference includes more than 1,200 talks and presentations on the latest results from basic and clinical science in diabetes research discussed by leading experts in the field.

EASD 2025 will be a landmark event for healthcare professionals, researchers and stakeholders in the diabetes community, exploring trends, innovations and the overall impact on diabetes management. With a focus on cutting-edge research, the conference will present the latest breakthroughs in diabetes treatment, technology and patient care

Being Diabetes one of the new main focus of the Company, this year we will participate with a 100sqm Exhiition Space and 1 symposium